Abiopharma

🔍 Davidson Phillip S (Director)

Company: PAR PACIFIC HOLDINGS, INC. (PARR)

Report Date: 2026-04-05

Detailed Transactions and Holdings:

• Acquired 440 shares of Common stock at $64.89 per share (Direct)
  Date: 2026-04-05 | Code: J | equity_swap_involved: 0 | shares_owned_after: 9,004.00 | transaction_form_type: 4
• Acquired 385 shares of Restricted stock units (Derivative)
  Date: 2026-04-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 385.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 440 shares of Restricted stock units (Derivative)
  Date: 2026-04-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 440.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
• F2: The restricted stock unit will vest in full on April 5, 2027. Vested shares will be delivered to the reporting person following termination of service.
• F3: On April 5, 2026, 440 restricted stock units were delivered to the reporting person as common stock.